A Phase I Study of Allogeneic Mesenchymal Stem Cell Therapy in Patients with Heart Failure Secondary to Anthracycline-induced Cardiomyopathy: The Cctrn Stem Cell Injection in Cancer Survivors (Seneca) Trial Bolli, R., Perin, E. C., Willerson, J. T., Yang, P. C., Traverse, J. H., Henry, T. D., Pepine, C. J., Mitrani, R. D., Hare, J. M., Murphy, M. P., Lima, J. A., Gee, A. P., Taylor, D. A., Lai, D., Ebert, R. F., Davis, B. R., Simari, R. D. CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS. 2020: S97

View details for Web of Science ID 000579889600259